We are thrilled to announce that FeelBetter has successfully raised $10 million in its latest funding round, a milestone that underscores our commitment to transforming patient care through innovative technology. As a pioneer in utilizing AI to address the critical issue of polypharmacy, FeelBetter has developed a cutting-edge solution designed to identify patients at high risk of near-term hospitalization due to complex medication regimens. Our technology doesn't stop at identification; it proactively recommends necessary changes to medication schedules and clinical interventions tailored to individual patient needs. This substantial funding will be instrumental in further enhancing our platform's capabilities, allowing us to incorporate advanced predictive analytics and machine learning models that refine our ability to monitor patient progress on both individual and population health levels. With this new infusion of capital, we plan to expand our outreach, deepen our research initiatives, and foster strategic partnerships that align with our mission to improve the quality of healthcare management. As we move forward, we remain steadfast in our dedication to reducing hospitalizations and improving outcomes for patients navigating the complexities of multiple medications, ultimately creating a healthier future for all. Thank you to our investors for believing in our vision and joining us on this crucial journey toward safer medication practices and better health for vulnerable populations.












